Financials
Income statement
| Fiscal date | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total reported revenue | 36.0B | 29.8B | 25.8B | 24.6B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | 425.3M | 972.3M | 718.1M |
| Other operating expenses | 1.3B | 514.2M | 520.7M | 506M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 36.4B | 28.4B | 22.9B | 23.5B |
| Tax provision | 9.3B | 7.3B | 5.9B | 6.3B |
| Net income | 27.1B | 21.2B | 17.0B | 17.2B |
| Basic EPS | — | 10.6 | 8.5 | 8.6 |
| Diluted EPS | — | 10.6 | 8.5 | 8.6 |
| Basic average shares | — | 2.0B | 2.0B | 2.0B |
| Diluted average shares | — | 2.0B | 2.0B | 2.0B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 36.4B | 28.4B | 22.9B | 23.5B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |